1 / 8

Atrial Fibrillation Market Growing at 14.0% CAGR to be Worth USD 18,085 Million

According to a new market research study of u2018Atrial Fibrillation Market to 2027 u2013 Global Analysis and Forecasts by Treatment Type and End User.u2019 The global atrial fibrillation market is expected to reach US$ 18,085.96 Mn in 2027 from US$ 6,446.08 Mn in 2019. The market is estimated to grow with a CAGR of 14.0% from 2020-2027. The report provides trends prevailing in the global Atrial Fibrillation Market and the factors driving the market along with those that act as hindrances.<br>Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00003531/ <br>Atrial fibrillation, is the most common typ

Shubham46
Download Presentation

Atrial Fibrillation Market Growing at 14.0% CAGR to be Worth USD 18,085 Million

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Atrial Fibrillation Market Global Analysis and Forecast to 2028 Email: sales@theinsightpartners.com

  2. Email: sales@theinsightpartners.com Report Studies  Atrial Fibrillation Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Treatment Type (Non-pharmacological, Pharmacological); End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories); and Geography 2

  3. Email: sales@theinsightpartners.com Atrial Fibrillation Market Overview  The Atrial fibrillation market was valued at US$ 6,446.08 million in 2019 and is expected to grow at a CAGR of 14.0% from 2020 to 2027 to reach US$ 18,085.96 million by 2027.  Atrial fibrillation, is the most common type of heart disorder, where the heart beats too fast, too slow, or in an irregular way. The Centers for Disease Control and Prevention (CDC) estimated that between 2.7 million and 6.1 million people are suffering from AFib in the United States. In 2017, around 166,793 death certificates mention AFib and was the main cause death in 26,077 deaths. Every year over 454,000 hospitalizations were due to AFib in the United States and every year about 158,000 deaths are due to atrial fibrillation. 3

  4. Email: sales@theinsightpartners.com Key Segment Market Segment :-  by Treatment Type (Non-pharmacological, Pharmacological)  End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories)  Geography 4

  5. Email: sales@theinsightpartners.com $50,000 Atrial Fibrillation Market Value $40,000 $30,000 CAGR of 14.0% $20,000 (2020-2027) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5

  6. Email: sales@theinsightpartners.com Company Profiles  Boston Scientific Corporation  Medtronic  AtriCure, Inc  Biosense Webster, Inc.  BOEHRINGER INGELHEIM GMBH  CardioFocus  Abbott  Sanofi  Biotronik Inc.  Bristol-Myers Squibb Company 6 Download Sample Here

  7. Email: sales@theinsightpartners.com By Geography  North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)  Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7

  8. THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related